Exposure to High-Dose Liraglutide in a Pregnant Woman With Obesity
This case report demonstrates a normal pregnancy outcome after exposure to a high dose of liraglutide during the first 7 weeks of pregnancy, apart from a low birth weight. These findings enhance the limited understanding of liraglutide exposure during pregnancy. More studies are required to establish a causal relationship between neonatal weight and liraglutide exposure. Longitudinal follow-up of children beyond 14 months is essential to evaluate growth and neurodevelopmental outcomes and assess any long-term teratogenic effects from anti-obesity drugs.
Authors
- Daoud Al‐Badriyeh (ORCID: https://orcid.org/0000-0001-7791-954X)
- Yolande Hanssens (ORCID: https://orcid.org/0000-0002-3859-8648)
- Wessam Elkassem (ORCID: https://orcid.org/0000-0003-2145-7555)
- Binny Thomas (ORCID: https://orcid.org/0000-0003-1065-8343)
- Dina Abushanab (ORCID: https://orcid.org/0000-0002-4162-8617)
- Moza Al Hail (ORCID: https://orcid.org/0000-0003-4991-982X)
- Shabina Khan
- Haseebur Rahman Mohammed
- Shaban Mohammed
- Palli Valappila Abdul Rouf
- Halima Al-Mohannadi
Institutions
- Hamad Medical Corporation (QA)
Publication Details
- Journal
- O&G Open
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1097/og9.0000000000000077
- Citations
- 3
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 3.88